Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment (TIME) and identifies a combination biomarker for primary melanoma

Patients with resected stage II-III melanoma have approximately a 35% chance of death from their disease. A deeper understanding of the tumor immune microenvironment (TIME) is required to stratify patients and identify factors leading to therapy resistance. We previously identified that the melanoma...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Res
Prif Awduron: Gartrell-Corrado, Robyn D., Chen, Andrew X., Rizk, Emanuelle M., Marks, Douglas K., Bogardus, Margaret H., Hart, Thomas D., Silverman, Andrew M., Bayan, Claire-Audrey Y., Finkel, Grace G., Barker, Luke W., Komatsubara, Kimberly M., Carvajal, Richard D., Horst, Basil A., Chang, Rui, Monod, Anthea, Rabadan, Raul, Saenger, Yvonne M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7112471/
https://ncbi.nlm.nih.gov/pubmed/31948941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-19-2039
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg